Home › Stocks › PCRX › All Fund Holders
PCRX — PACIRA BIOSCIENCES INC · All Fund Holders
Funds holding (latest): 47 · Reported value held: $548.21M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 4.81M | $124.56M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 1.95M | $49.48M | 0.03% | Reduce |
| Renaissance Technologies history | Q2 2026 | 1.73M | $43.99M | 0.06% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 1.53M | $38.74M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 1.16M | $29.40M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 1.14M | $29.04M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 920.22K | $23.35M | 0.00% | Add |
| Baillie Gifford & Co history | Q2 2024 | 806.10K | $23.06M | 0.02% | Reduce |
| Paulson & Co history | Q2 2022 | 350.00K | $20.41M | 1.05% | Reduce |
| Point72 Asset Management history | Q4 2024 | 1.08M | $20.27M | 0.05% | New |
| Two Sigma Investments history | Q2 2026 | 724.60K | $18.38M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 690.79K | $17.53M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 563.46K | $14.29M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 526.78K | $13.36M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 296.88K | $7.53M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 281.02K | $7.13M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 249.35K | $6.33M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 240.01K | $6.09M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 235.16K | $5.97M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 5.95M | $5.93M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 162.16K | $4.11M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 158.51K | $4.02M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 3.98M | $3.96M | 0.00% | Reduce |
| First Eagle Investment Management history | Q4 2023 | 103.08K | $3.48M | 0.01% | Reduce |
| PSP Investments history | Q2 2026 | 135.19K | $3.43M | 0.01% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.43M | $3.42M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 129.35K | $3.28M | 0.00% | New |
| Balyasny Asset Management history | Q1 2026 | 106.42K | $2.41M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 88.64K | $2.25M | 0.00% | Reduce |
| Moore Capital Management history | Q2 2023 | 55.00K | $2.20M | 0.04% | New |
| Prudential Financial history | Q2 2026 | 79.70K | $2.02M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q2 2026 | 76.00K | $1.93M | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 37.48K | $950.89K | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 35.61K | $903.45K | 0.00% | Add |
| Arrowstreet Capital history | Q1 2026 | 36.97K | $835.43K | 0.00% | Reduce |
| MFS Investment Management history | Q2 2026 | 31.18K | $790.99K | 0.00% | New |
| Franklin Resources history | Q1 2026 | 32.92K | $744.04K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 627.00K | $629.14K | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 23.32K | $526.78K | 0.00% | Hold |
| Amundi US history | Q2 2026 | 15.89K | $403.23K | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 10.35K | $262.58K | 0.00% | Reduce |
| Maverick Capital history | Q2 2023 | 5.82K | $233.33K | 0.01% | New |
| Royce & Associates history | Q3 2023 | 6.80K | $208.72K | 0.00% | Reduce |
| CPP Investments history | Q4 2025 | 7.70K | $199.28K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 3.74K | $94.86K | 0.00% | Hold |
| Lazard Asset Management history | Q2 2026 | 8.48M | $84.68K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 61.86K | $1.57K | 0.00% | Add |